Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma: a retrospective real-world study.

Front Immunol · 2025 · PMC12546067 · PMID 41142819

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The plots highlight variables associated with favorable outcomes (e.g., PLR ≤ 165.6, on-treatment CA19–9 decline), whereas other covariates did not reach statistical significance (95% CI crossing HR = 1). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.